2 completed, 1 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Terminated 1 |
Follow iclaprim: new trials by email Literature Review of iclaprim trials Research Report on iclaprim
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2 Iclaprim, Vancomycin - Skin Structures and Soft Tissue Infections | Phase 3 | Completed | Motif Bio | 613 | 2015-11-01 | 2018-08-07 |
| Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1 iclaprim, vancomycin - Skin Structures and Soft Tissue Infections | Phase 3 | Completed | Motif Bio | 600 | 2015-11-01 | 2018-06-19 |
| Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia iclaprim, vancomycin - Hospital-Acquired Pneumonia, Ventilator-Associated Pneumonia | Phase 2 | Terminated | Arpida AG | 135 | 2007-11-01 | 2009-02-13 |
Soft Tissue Infections (2) · Healthcare-Associated Pneumonia (1) · Pneumonia (1) · Pneumonia, Ventilator-Associated (1)
United States (2) · Argentina (1) · Belgium (1) · Bulgaria (1) · Chile (1) · Colombia (1) · Croatia (1) · Czechia (1) · Estonia (1) · Germany (1) · Hungary (1) · Latvia (1) · Peru (1) · Poland (1) · Portugal (1)
David Huang, MD, PhD (1) · David Willms, MD (1) · Stephanie Noviello, MD (1)